Enjoy complimentary customisation on priority with our Enterprise License!
The compounding pharmacy market size is forecast to increase by USD 1.64 billion at a CAGR of 2.09% between 2023 and 2028. The market is experiencing significant growth due to several key factors. The increasing preference for personalized medicines, particularly in the form of capsules and suppositories, is driving demand. Healthcare providers, including doctors' offices and hospitals, are increasingly turning to compounded medications to meet the unique needs of their patients. Traditional pharmacies and community pharmacies are also recognizing the value of compounded medications and expanding their offerings. However, the market faces challenges, including concerns over the safety and quality of compounded drugs due to the lack of standardization and regulation. Ensuring the safe usage of compounded medications is essential to mitigate risks and maintain patient safety.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Therapeutic Area
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.